Home › Funds › Jones Hill Capital LP › ACRS
Jones Hill Capital LP position in ACRS
ACLARIS THERAPEUTICS INC · Health Care
Jones Hill Capital LP reported holding 2,504,651 shares of ACRS (ACLARIS THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$13.2M, representing 2.24% of its reported portfolio and ranking #15 among its reported holdings. Jones Hill Capital LP has disclosed ACRS holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Jones Hill Capital LP's ACRS position evolved
Jones Hill Capital LP first disclosed a stake in ACRS in Q2 2026 at 1,759,492 shares (US$9.3M). The position peaked in Q3 2026 at 2,504,651 shares, worth US$13.2M. Across 2 filings, Jones Hill Capital LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 2,504,651 shares valued at US$13.2M — an increase of 745,159 shares quarter over quarter.. Notable position changes include a 42% increase in Q3 2026 (shares fell 25% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 1.76M | $9.31M | New |
| Q3 2026 | 2.50M | $13.17M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ACRS and 13F data
ACRS (ACLARIS THERAPEUTICS INC) is a Health Care company. 44 other funds we track also report a position in ACRS — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$67.3M), BML Capital Management, LLC (US$57.6M), Deep Track Capital, LP (US$49.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ACRS
- RA CAPITAL MANAGEMENT, L.P. 12.72M sh · $67.30M · Q2 2026
- BML Capital Management, LLC 10.96M sh · $57.62M · Q3 2026
- Deep Track Capital, LP 9.35M sh · $49.44M · Q2 2026
- Vivo Capital, LLC 6.69M sh · $35.21M · Q3 2026
- Frazier Life Sciences Management, L.P. 4.93M sh · $26.06M · Q2 2026
- Rock Springs Capital Management LP 4.33M sh · $22.91M · Q2 2026
- Decheng Capital LLC 4.04M sh · $21.38M · Q2 2026
- Kalehua Capital Management LLC 1.83M sh · $9.64M · Q3 2026
- Palo Alto Investors LP 1.61M sh · $8.54M · Q2 2026
- MPM BioImpact LLC 1.04M sh · $5.51M · Q2 2026
- Aldebaran Capital, LLC 936.18K sh · $4.92M · Q3 2026
- Three Bridge Wealth Advisors, LLC 714.82K sh · $3.76M · Q3 2026
More on Jones Hill Capital LP
FAQ
How long has Jones Hill Capital LP held ACRS?
Jones Hill Capital LP has disclosed ACRS holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Jones Hill Capital LP's current position in ACRS?
As of Q3 2026, Jones Hill Capital LP holds 2.50M shares of ACRS (ACLARIS THERAPEUTICS INC), valued at $13.17M, representing 2.24% of its reported portfolio and ranking #15.
Has Jones Hill Capital LP been buying or selling ACRS?
In the latest 13F filing (Q3 2026), Jones Hill Capital LP increased its position in ACRS. The position peaked in Q3 2026 at 2.50M shares.
Which other funds hold ACRS?
Other major institutional holders of ACRS include RA CAPITAL MANAGEMENT, L.P., BML Capital Management, LLC, Deep Track Capital, LP, among 44 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.